|
SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
RECRUITINGSponsored by Mayo Clinic
Actively Recruiting
SponsorMayo Clinic
Started2026-08-25
Est. completion2028-08-25
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07850284
Summary
This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Age \>= 18 years * Diagnosis of MM or AL based on IMWG diagnostic criteria * Planned to start a new treatment within 14 days (+/-7 days) * Able to provide written informed consent Exclusion Criteria: * Not able to give informed consent
Conditions3
AL AmyloidosisCancerMultiple Myeloma
Locations1 site
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorMayo Clinic
Started2026-08-25
Est. completion2028-08-25
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07850284